Quick answerWarfarin-associated major hemorrhage. Actions: administer the prescribed IV 4-factor PCC; administer the prescribed IV vitamin K. Monitor: blood pressure and heart rate, and hemoglobin level.
Why this is correctAmiodarone inhibits warfarin metabolism, which explains the INR of 6.8. Major bleeding with hemodynamic instability requires immediate reversal: 4-factor prothrombin complex concentrate replaces factors II, VII, IX, and X within minutes, and IV vitamin K allows the liver to make new factors so the INR does not rebound. The mechanical valve raises thrombosis concern, but a life-threatening bleed takes priority, and anticoagulation is resumed later once bleeding is controlled.
Easy analogy or mental picturePCC is the fire hose that puts out the fire now; IV vitamin K is the sprinkler system that keeps it from reigniting after the hose is turned off.
Memory hookBleeding and shocked on warfarin: PCC now plus vitamin K IV.
NCLEX decision ruleFor life-threatening anticoagulant bleeding, choose rapid reversal plus sustained reversal; save management of the indication for anticoagulation until the bleeding is controlled.
Why the other choices are wrongSupratherapeutic INR without bleeding is ruled out by the CT and hemoglobin fall; oral vitamin K or holding warfarin with a 24-hour recheck is correct only in that situation. Valve thrombosis would cause a muffled click or new murmur, which are absent, so valve click quality is the wrong trend. Septic shock is unlikely with a normal temperature and WBC. A heparin infusion to protect the valve is appropriate later, after bleeding is controlled, not now. TSH tracks a later amiodarone adverse effect, not the bleed.
References
1DailyMed — KCENTRA (prothrombin complex concentrate, human)Indicated for urgent reversal of vitamin K antagonist in acute major bleeding, given with vitamin K.
2DailyMed — Warfarin sodium prescribing informationBleeding risk and interactions that increase INR, including amiodarone.